Literature DB >> 11715309

[Gross tumor volume (GTV) and clinical target volume (CTV) in adult gliomas].

G Kantor1, H Loiseau, A Vital, J J Mazeron.   

Abstract

Glioblastoma multiform and astrocytoma are the most frequent primary cancer of the central nervous system of adult. Definitions of gross tumor volume (GTV) and clinical target volume (CTV) are based on the confrontation of clinical presentation (age, performance status, neurologic symptoms...), histological type and imaging aspects. For glioblastoma multiform, the GTV can be defined by the area of contrast enhancement observed on the CT scan or MRI. Definition of the CTV can be more difficult and have to take into account the risk of presence of isolated malignant cells in the oedema surrounding the tumor or in the adjacent brain structures. The classical concept of GTV plus a safety margin of 2 cm around is discussed with a CTV containing at least all the oedematous area and eventually adjacent brain structures (nuclei, corpus callosum or other long associative fibers...). For low grade astrocytoma, the definition of GTV can be difficult if the tumoral infiltration is diffuse without nodular visible tumor. CTV corresponds to at least T2 MRI hypersignal area when visible. For postoperative tumor, technical considerations are important for the detection of residual tumor. A safety margin around the resected area is designed according to the risk of presence of isolated cells or involvement of adjacent brain structures.

Entities:  

Mesh:

Year:  2001        PMID: 11715309     DOI: 10.1016/s1278-3218(01)00107-x

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  1 in total

1.  Realistic simulation of the 3-D growth of brain tumors in MR images coupling diffusion with biomechanical deformation.

Authors:  Olivier Clatz; Maxime Sermesant; Pierre-Yves Bondiau; Hervé Delingette; Simon K Warfield; Grégoire Malandain; Nicholas Ayache
Journal:  IEEE Trans Med Imaging       Date:  2005-10       Impact factor: 10.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.